Monocyte-to-macrophage differentiation is tightly controlled in vivo, as disruption of the normal differentiation program can lead to diverse disorders. Caspase-1, the first identified member of the caspase family, regulates differentiation in various cell types such as Th17 cells and adipocytes. However, the contribution of caspase-1 in monocyte-macrophage differentiation remains elusive. Here we report that caspase-1 is significantly downregulated in leukemia cells from patients with acute monocytic leukemia. By using the phorbol 12-myristate 13-acetate-induced cell differentiation model, we found that caspase-1 activation was required for the differentiation of human monocytes to macrophages. Further analysis of peroxisome proliferator-activated receptor c (PPARc) protein levels revealed that the monocyte-macrophage differentiation program could be divided into two stages. Caspase-1-mediated downregulation of PPARc was important in the late stage of monocyte-macrophage differentiation; however, PPARc protein levels had little effect on the early stage differentiation. Accumulation of PPARc protein by troglitazone treatment potently suppressed the late stage of macrophage differentiation, which might be linked to inhibition of nuclear factor-jB activity. The data provide a plausible mechanistic basis by which caspase-1 promotes the differentiation of macrophages from monocytes.
Introduction
Monocytes are peripheral immune cells that can differentiate into macrophages in the presence of various cytokines and microbial stimuli [1] . The process of monocyte-to-macrophage differentiation is accompanied by marked changes in cell morphology and expression of cell surface markers, and more importantly the acquisition of immune functions [2] . Deregulation of macrophage differentiation is tightly associated with the pathogenesis of inflammatory diseases, atherosclerosis, tumors [3, 4] , and most importantly the pathogenesis of acute monocytic leukemia, which is classified as the M5 subtype of acute myeloid leukemia (AML) based on morphology by the French-American-British classification. AML-M5 may be subdivided into M5a and M5b by the relative proportion of monoblasts and promonocytes [5] . Besides unusual bleeding, M5 patients are more likely to experience a life-threatening condition termed disseminated intravascular coagulation (DIC) that leads to rectal bleeding and brain hemorrhage [6] . Therefore, identifying factors that regulate monocyte-to-macrophage differentiation would be of great biological and therapeutic relevance.
Caspases are highly conserved cysteinyl-aspartatespecific proteinases, which not only play central roles in regulating apoptotic and inflammatory signaling pathways, but also have functions in cell survival, proliferation and differentiation [7] . Recent findings have clarified the important involvement of several caspases in controlling monocyte-to-macrophage differentiation [8] . Conditional knockout of caspase-8 in bonemarrow cells resulted in arrest of macrophage differentiation [9] . Consistent with this, in vitro studies indicated that caspase-8 activation was required for the differentiation of human monocytes into macrophages [10, 11] . In addition, caspase-3 activity is involved in both interleukin (IL)-32c-induced macrophage differentiation of human monocytes and macrophage colony-stimulating factor (M-CSF)-and IL-3-induced monocytic differentiation of primary mouse progenitor cells [12, 13] . These findings have underscored important regulatory roles for caspases in cell differentiation, and prompted us to investigate the potential functions of other members of the caspase family in macrophage differentiation.
Caspase-1 is the prototypical member of the subset of inflammatory caspases, which is activated mainly through four inflammasome complexes, including NLRP1 (NLRP1, caspase-1), NLRP3 (NLRP3, ASC, caspase-1), NLRC4 (NLRC4, caspase-1), and AIM2 (AIM2, ASC, caspase-1) inflammasomes [14] . Similarly to apoptotic caspases (such as caspase-3 and caspase-8), caspase-1 also participates in programmed cell death, cell survival and differentiation. Notably, there is evidence supporting a direct role for caspase-1 in regulating differentiation process of various cell types. Caspase-1 activity is required for myoblast differentiation of L8 cells and neuronal differentiation of PC12 cells by specifically targeting calpastatin for degradation [15, 16] . Moreover, caspase-1 can control Th17 cells and adipocyte differentiation, which is largely conveyed by IL-1b signaling [17] [18] [19] . Although different mechanisms are engaged by caspase-1 depending on the cell type, the general role of caspase-1 in the control of cell differentiation has been established.
Over the past few years, caspase-1 has been regarded as a key mediator in macrophage activation by promoting maturation and secretion of pro-inflammatory cytokines IL-1b and IL-18, and by regulating nuclear factor-jB (NF-jB) signaling [20, 21] . However, the extended role of caspase-1 in regulating the process of monocyte-to-macrophage differentiation is not known. In this study, we report that monocyte-to-macrophage differentiation requires caspase-1 activity. Based on the findings that the activity of caspase-1 was elevated during macrophage differentiation of THP-1 and U937 cells and primary blood monocytes, we investigated the effects of caspase-1 on macrophage surface marker expression and phagocytic ability, and found that caspase-1 was necessary for human macrophage differentiation. Previous studies have demonstrated that caspase-1 could regulate the expression and activity of nuclear receptor peroxisome proliferator-activated receptor c (PPARc) [22] , which is expressed in adipose tissue, colon, the immune system, hematopoietic cells and retina, and involved in lipid anabolism, adipocyte differentiation, control of inflammation and embryo implantation [23] , and also plays a role in the control of macrophage differentiation [24] . Accordingly, we assessed the effects of caspase-1 on the expression of PPARc in macrophages and in inflammasomereconstituted HEK293T cells. Our data suggest that caspase-1 plays a certain role in both early and late stages of macrophage differentiation; that PPARc might have distinct roles during the early and late stages of macrophage differentiation; and that in the late stage, caspase-1 promotes macrophage maturation by tuning down the expression of PPARc.
Results

Caspase-1 was downregulated in AML-M5b leukemia cells
In a candidate screen we found that in AML-M5b leukemia cells, the abundance of caspase-1 was significantly downregulated. As shown in Fig. 1A , a considerable proportion of promonocytes were accumulated in bone marrow of AML-M5b patients. Importantly, the protein level of caspase-1 was significantly downregulated in leukemia cells (Fig. 1B,C) . Consistent with this, the mRNA level of caspase-1 in mononuclear cells isolated from bone marrow samples was also markedly lower in AML-M5b patients compared with that in healthy donors (five cases in each group) (Fig. 1D) . Notably, the activity of caspase-1 in leukemia cells was also downregulated (Fig. 1E) . These results suggested that downregulation of caspase-1 might be linked to the accumulation of monocytes and errors in monocyte differentiation observed in patients with AML-M5b.
Activation of caspase-1 during phorbol 12-myristate 13-acetate-induced macrophage differentiation
The fact that caspase-1 was downregulatedin AMLM5b leukemia cells prompted us to examine whether caspase-1 is required for monocyte-to-macrophage differentiation. Previous studies demonstrated that M5-type AML cell lines such as THP-1 and U937 represent good models for studying monocytic differentiation in vitro [25, 26] . Following exposure to 50 nM phorbol 12-myristate 13-acetate (PMA), THP-1 cells became adherent to the culture plate during 24 h, and were flattened with extensive pseudopodia within 48 h ( Fig. 2A) . To further characterize PMA-induced macrophage differentiation of THP-1 cells, we performed a time course analysis of several macrophage surface markers by RT-PCR. PMA treatment triggered a significant increase in gene expression of CD11b, CD14, CD36 and CD71 during 24 h (Fig. 2B) .
Correspondingly, the cell surface expression of CD11b and CD14 was also markedly elevated at 48 h (Fig. 2C) . Similar results were obtained in U937 cells (Fig. 2D) . Importantly, the uptake of opsonized latex beads was intensively induced in THP-1 cells differentiated for 48 h, indicative of full differentiation into functional macrophages (Fig. 2E,F) . Thus, PMA treatment could induce the characteristic macrophage phenotype in THP-1 and U937 cells.
To explore the role of caspase-1 in monocytic differentiation, we examined whether caspase-1 is activated in response to differentiation stimuli. Although caspase-1 was constitutively expressed by THP-1 cells (Fig. 2G) , its activity was obviously induced by PMA treatment during macrophage differentiation. Active caspase-1 was increased in PMA-differentiated THP-1 cells, as indicated by increased binding of FAM-YVAD-FMK (Fig. 2H) . PMA-induced caspase-1 activation was also associated with considerable release of Fig. 1 . Caspase-1 expression and activity in acute monocytic leukemia (AML-M5b) cells. (A) Representative pictures of Wright's staining of bone marrow smears prepared from healthy volunteers and patients with AML-M5b, respectively. Images were obtained by oil-immersion microscopy. Scale bar, 50 mm. (B) Immunofluorescence staining of bone marrow monocytes using an anti-caspase-1 antibody and a Cy3-labeled goat anti-rabbit IgG (H+L) antibody, then subjected to confocal fluorescence microscopy analysis. DAPI, 4 0 ,6-diamidino-2-phenylindole. Scale bar, 50 mm. (C, D) Analysis of caspase-1 protein or gene expression in bone marrow monocytes from M5b patients and healthy donors by using western blot (C) or RT-qPCR (D). Each point represents mRNA expression analysis of a single subject. CYPA, cyclophilin A; GAPDH, glyceraldehyde 3-phosphate dehydrogenase. Results represent the mean AE SEM of three independent experiments (n = 5, **P < 0.01, as determined by Student's t test) (D). (E) Flow cytometry analysis of caspase-1 activity in bone marrow monocytes from M5b patients and healthy donors using the fluorescent peptide FAM-YVAD-FMK. MFI, mean fluorescence intensity. Results represent the mean AE SEM of three independent experiments (**P < 0.01, as determined by Student's t test).
active caspase-1 and IL-1b (Fig. 2I) . And the secretion of IL-1b in PMA-differentiated THP-1 cells was significantly increased, as indicated by ELISA analysis, and was inhibited by the caspase-1 inhibitor WEHD (Fig. 2J) . Consistent with results obtained in THP-1 cells, caspase-1 activity was elevated upon PMA treatment in U937 cells, although its expression level was not affected (Fig. 2K,L ). In agreement with our results, Kong et al. [27] recently reported that PMA induced caspase-1 activation and IL-1b and IL-18 release in THP-1 cells. In total, these results have clearly demonstrated that activation of caspase-1 was associated with PMA-induced macrophage differentiation in THP-1 cells.
Caspase-1 inhibition suppressed macrophage differentiation
Based on the above observations, we assumed that the increased activity of caspase-1 might be necessary for the macrophage differentiation program. To test this hypothesis, we made use of the specific caspase-1 inhibitor, WEHD. WEHD exhibited a negative effect on macrophage differentiation, as indicated by studying the dose-and time-dependent appearance of the macrophage marker CD11b (Fig. 3A,B) . In addition to CD11b, the mRNA level of CD14 and CD71 was also obviously inhibited by WEHD treatment (50 lM), while CD36 expression was not affected (Fig. 3C) . Compared with WEHD, the caspase-3-specific inhibitor DEVD had little effect on CD11b expression, while the pan-caspase inhibitor z-VAD exhibited the most potent inhibitory effect (Fig. 3D) . Consistent results were also obtained from U937 cells in parallel CD11b expression detection experiments (Fig. 3E) . Furthermore, WEHD treatment restrained the phagocytic activity of PMA-differentiated cells (Fig. 3F) . These results supported the hypothesis that caspase-1 activity was required for macrophage differentiation.
We further examined the regulatory role of caspase-1 during macrophage differentiation of human peripheral blood mononuclear cells (PBMCs) by using a colorimetric method. As shown in Fig. 3G , caspase-1 activity was obviously elevated by M-CSF (100 ngÁmL
À1
) or granulocyte-macrophage colony stimulating factor (GM-CSF; 100 ngÁmL À1 ) treatment. Notably, WEHD exhibited a strong inhibitory effect on M-CSF-induced expression of CD11b and CD14 at the protein level (Fig. 3H ). In total, these results have established an important role for caspase-1 activation in controlling monocyte-to-macrophage differentiation.
Because NLRP1, AIM2, NLRC4 and NLRP3 inflammasomes are involved in caspase-1 activation [14] , we assessed mRNA expression levels for inflammasome components. As indicated in Fig. 3I ,J, we found that almost all of the tested inflammasome components were upregulated in the differentiation of PBMCs (Fig. 3I) , while in the differentiation of THP-1 macrophages (Fig. 3J) , only NLRP3 and AIM2 were upregulated.
Loss of function of caspase-1 restrained macrophage differentiation
Since caspase-1 was constitutively expressed in THP-1 and U937 cells (Fig. 2G,K) , we reasoned that knockdown of caspase-1 would inhibit caspase-1 activity and thus hinder the macrophage differentiation program. To test this prediction, we first generated THP-1 cells stably expressing shRNA that targets caspase-1 (Tshcasp-1) or expressing a scrambled shRNA (Tscramble) by viral transduction and cell sorting (Fig. 4A) . We next tested the knockdown efficiency by immunoblot analysis. As shown in Fig. 4B , the expression of caspase-1 protein was sharply reduced by shRNA. Remarkably, PMA-induced expression of CD11b was inhibited by caspase-1 shRNA, as indicated by Q-PCR analysis (Fig. 4C) . Accordingly, knockdown of caspase-1 resulted in a dramatic decrease of CD11b expression at the cell surface (Fig. 4D ). There was no significant difference in CD14 expression between Tshcasp-1 and Tscramble cells at the mRNA level (Fig. 4C) , though inhibition of caspase-1 significantly suppressed CD14 expression in a murine macrophage differentiation model (Fig. 3H) . Furthermore, PMAinduced Tshcasp-1 cells exhibited an impairment of phagocytic activity (Fig. 4E) . Furthermore, lipopolysaccharide (LPS)-induced IL-1b, IL-6 and tumor necrosis factor a (TNF-a) release were intensively inhibited by caspase-1 knockdown (Fig. 4F) . We have also generated caspase-1 knockdown U937 cells ( Fig. 4G,H) . In a similar manner, knockdown of caspase-1 expression could suppress CD11b expression in U937 cells (Fig. 4I ). To further explore the role that caspase-1 plays in macrophage differentiation, we generated caspase-1-deficient THP-1 cells by using the CRISPR/Cas9 system. We found that knockout of caspase-1 suppressed the expression of CD11b and another macrophage differentiation marker, CD68 [28] , at both 24 and 48 h (Fig. 4J) . Moreover, when we incubated mouse bone marrow cells with 20 ngÁmL À1 M-CSF to induce macrophage (bone marrow-derived macrophages) differentiation, we also found that macrophage differentiation was impaired in caspase-1 knockout cells from caspase-1 À/À mice (Fig. 4K ). The knockout efficiency of caspase-1 in THP-1 cells and mouse bone marrow cells was verified by western blotting (Fig. 4L ,M). Taken together, these findings offered solid evidence that caspase-1 played an essential role in regulating PMA-induced macrophage differentiation or murine macrophage differentiation.
Activation of caspase-1-mediated downregulation of PPARc in THP-1 cells during the late stage of macrophage differentiation
As the relationship between caspase-1-processed cytokines (IL-1b and IL-18) and caspase-1-controlled cell differentiation has been developed [17, 19] , we wondered whether these cytokines were engaged by caspase-1 during macrophage differentiation. We noted that the mRNA level of IL-1b and its receptor IL-1R1 was increased in a time-dependent manner ( Fig. 5A) , and the secretion of IL-1b was evident in the supernatant upon PMA treatment (Fig. 2J ). To determine the contribution of IL-1b in regulating macrophage differentiation, we added exogenous IL-1b to the cell culture in the presence or absence of PMA treatment.
The results indicated that augmented IL-1b signaling had only a marginal effect on CD11b expression (Fig. 5B,C) . Conversely, attenuation of IL-1b signaling by adding IL-1b-neutralizing antibody could not substantially inhibit macrophage differentiation (Fig. 5B,  D) . Moreover, IL-18 was also released during PMAinduced differentiation (Fig. 5E ). However, IL-18 was not involved in regulating macrophage differentiation (Fig. 5F ). Collectively, these data demonstrated that IL-1b and IL-18 were dispensable for caspase-1-regulated macrophage differentiation, and suggested that some other factors regulated by caspase-1 might be involved in this process. Genetic studies with loss-of-function or gain-offunction experiments have defined the key roles of transcription factors in specifying monocyte/macrophage fates [29] . Specifically, earlier reports have demonstrated that nuclear receptor PPARc could promote macrophage differentiation in vitro and was required for osteoclastogenesis in mice [24, 30] . Notably, the expression and activity of PPARc might be regulated by caspase-1 [19, 22] . Consequently, we hypothesized that caspase-1 might exert influences on macrophage differentiation via tuning of PPARc (Fig. 6B, lower panel) . Similarly, WEHD treatment could also elevate the expression of PPARc protein in U937 cells (Fig. 6C) . Consistent with this, shRNA against caspase-1 showed the same effect on expression of PPARc protein as caspase-1 inhibitor (Fig. 6D ). More importantly, in M-CSFinduced differentiation of PBMCs we also observed the two-stage expression of PPARc, which is upregulated during days 1-3, but downregulated during days 3-6 (Fig. 6E ). And caspase-1 inhibitor WEHD also prevented the downregulation of PPARc protein in PBMCs' late stage differentiation (Fig. 6F) . These results suggested that activation of caspase-1 was required for downregulation of PPARc protein during the monocyte-macrophage differentiation process; this effect was much more significant during the late stage of macrophage differentiation.
NLRP3 inflammasome downregulated PPARc protein in HEK293T cells
Abundant studies have shown that inflammasomes could activate caspase-1 [31] . To determine the effect of caspase-1 activation on PPARc expression, we employed an NLRP3 inflammasome reconstitution assay in HEK293T cells by transfecting plasmids for NLRP3, ASC and pro-caspase-1, as described in a previous study [32] . As shown in Fig. 7A , NLRP3 inflammasome could efficiently trigger caspase-1 activation, characterized by decreased expression of procaspase-1, increased expression of active caspase-1 (p20) and the presence of the mature form of pro-IL1b (p17), and this was inhibited by WEHD treatment. Moreover, we found that the expression of PPARc protein diminished considerably with the gradual increase of caspase-1 activity when we transfected the cells with increasing amounts of expression vector for NLRP3 (Fig. 7B) . However, the abundance of PPARc mRNA did not change with increasing expression of NLRP3, as indicated by RT-PCR analysis. Importantly, caspase-1-mediated downregulation of PPARc protein could be rescued by WEHD pretreatment (Fig. 7A) . These results further confirmed the phenomenon that caspase-1 tuned down the expression of PPARc, which was dependent on the enzyme activity.
Recombinant caspase-1 could cleave pro-IL-1b to generate the p17 fragment (Fig. 7C) . In addition, we found that downregulation of PPARc protein was not related to protease-mediated degradation (Fig. 7D) . Taken together, these data indicated that in HEK293T cells inflammasome-mediated caspase-1 activation induced significant downregulation of PPARc protein.
PPARc protein is important to macrophage late stage differentiation and has little effect on early stage differentiation
To assess whether caspase-1-mediated downregulation of PPARc protein was required for macrophage differentiation during the late stage, we tried to upregulate PPARc expression in THP-1 cells. We found that treatment with a high concentration of troglitazone (TGZ) induced an obvious increase in PPARc protein in PMA-differentiated cells, while the mRNA level remained unchanged (Fig. 8A,B) . TGZ could rescue PPARc downregulation in cytoplasmic and nuclear fractions of THP-1 cells at both 24 and 48 h (Fig. 8C) . With flow cytometry and RT-PCR assay, we found that TGZ treatment resulted in strong inhibition of PMA-induced macrophage differentiation in a dosedependent manner (Fig. 8D,E) . The inhibitory effect of TGZ on macrophage late stage differentiation was also reflected by impaired phagocytic ability (Fig. 8F) . It is intriguing that TGZ-mediated inhibition of macrophage differentiation was independent of PPARc transcriptional activity, as indicated by PPARc antagonist GW9662 treatment together with TGZ having no effect on macrophage differentiation (Fig. 8G) . These findings suggested that TGZ might be able to mimic the effect of caspase-1 inhibitor, thus hindering the macrophage differentiation process.
The monocytic differentiation program might be divided into two stages, namely an early stage (within 24 h) characterized by morphological changes and enhanced PPARc protein expression, and a late stage (ranging from 24 to 48 h) marked by significantly elevated cell surface marker expression, strongly enhanced phagocytic ability and decreased PPARc protein expression. We had already found that caspase-1 was important for both the early and late stages of macrophage differentiation (Fig. 4J) , and enhancing PPARc protein expression hindered late stage macrophage differentiation, so we wondered whether PPARc protein also plays a role in the early stage of macrophage differentiation. Our result demonstrated that TGZ failed to affect macrophage differentiation at 24 h, though TGZ could enhance PPARc expression at 24 h (Fig. 8C) , consistent with previous results, and TGZ inhibited the late stage differentiation (Fig. 8H) . Moreover, PPARc knockout had no effect on macrophage differentiation at 24 h, but promoted macrophage differentiation at 48 h (Fig. 8I) . PPARc knockout efficiency was verified by western blotting (Fig. 8J) .
Earlier studies have demonstrated that activation of NF-jB was required for macrophage differentiation [11, 33] . To demonstrate a link between the accumulation of PPARc protein and inhibition of NF-jB, we showed that overexpression of PPARc resulted in a significant decrease of NF-jB-dependent luciferase activity in 293T cells (Fig. 8K) . In agreement, the analysis of transcriptional activity by EMSA showed that activation of NF-jB was associated with macrophage differentiation (Fig. 8L, lanes 2-4) , and we employed TNFa (100 ngÁmL À1 , 1 h)-treated macrophage as a positive control of NF-jB activation (Fig. 8L, lane 5) . Noticeably, PPARc knockout significantly enhanced NF-jB activity (Fig. 8L, lane 6) ; however, caspase-1 knockout strongly inhibited NFjB activity (Fig. 8L, lane 7) , which correlated well with the accumulation of PPARc protein. Also, TGZ treatment evidently inhibited NF-jB activity (Fig. 8M) . In total, these results suggested that accumulation of PPARc protein might suppress macrophage differentiation by antagonizing the NF-jB transcriptional activity during the late stage. Results represent the mean AE SEM of three independent experiments (***P < 0.001, as determined by Student's t test). (I) Wild-type and PPARc knockout THP-1 cells were differentiated by PMA for the indicated time, and CD11b and CD68 expression were analyzed by flow cytometry. Results represent the mean AE SEM of three independent experiments (**P < 0.01, ***P < 0.001, as determined by Student's t test). (J) PPARc knockout efficiency in THP-1 cells was analyzed by immunoblot. (K) HEK293T cells were transfected with an NF-jB-luc reporter plasmid and p65 plasmid, along with increasing concentrations of PPARc plasmid, and NF-jB-dependent luciferase activity was analyzed. Results represent the mean AE SEM of three independent experiments (*P < 0.05, **P < 0.01, as determined by Student's t test). (L) NF-jB DNA-binding activity was analyzed by EMSA. Lane 8, isotype IgG control; lane 9, supershift using anti-p65; NC, negative control; ns, non-specific. (M) HEK293T cells were transfected with NF-jB-luc reporter plasmid and p65 plasmid, then pretreated with increasing concentrations of TGZ before TNFa treatment. NF-jB-dependent luciferase activity was assessed as indicated. Results represent the mean AE SEM of three independent experiments (*P < 0.05, **P < 0.01, as determined by Student's t test).
Discussion
Macrophages play a central role in orchestrating immune and inflammatory responses in lymphoid and nonlymphoid tissues. Most tissue macrophages are derived from circulating monocytes that originate in the bone marrow [34, 35] , yet molecular mechanisms underlying monocyte-to-macrophage differentiation have been scant. In the current study, we have presented solid evidence to demonstrate that caspase-1 activity played an important role in regulating macrophage differentiation in THP-1 and U937 cells and PBMCs by use of a caspase-1 specific inhibitor and caspase-1 knockdown or knockout. Mechanistically, caspase-1 could downregulate PPARc protein to prevent its accumulation, especially, during the late stage of macrophage differentiation, thus sustaining NF-jB activation and promoting the differentiation program. These data highlight a compelling role for a caspase-1-PPARc axis in regulating macrophage differentiation.
Activation of caspases often requires assembly of multicomponent complexes. During macrophage differentiation, M-CSF-macrophage colony-stimulating factor receptor signaling induces oscillatory activation of protein kinase B (AKT) and extracellular signalregulated kinases 1 and 2 (ERK1/2), which promotes association of procaspase-8 with Fas-associated protein with death domain (FADD) and subsequent activation of caspase-8 [36] . Herein we showed that several genes of inflammasome components were upregulated by PMA treatment (Fig. 3I,J) , which might favor inflammasome oligomerization [37] .
Caspase-1-mediated release of IL-1b and IL-18 plays important roles in regulating the maturation of immune cells. For instance, IL-1b is required for early differentiation of TH17 cells [17] , while IL-18 drives the differentiation of Th1, Th2 or Treg cells depending upon the cytokine milieu [38, 39] . However, we found that IL-1b and IL-18 induced by PMA treatment had little impact on the macrophage differentiation program, implying that non-canonical signaling regulated by caspase-1 might be involved in this process. Previous studies have indicated that the nuclear receptor PPARc played important roles in the control of macrophage differentiation, the expression of which was regulated by caspase-1 [22, 30] . As reported, we found that caspase-1 could tune down the expression PPARc protein during the late stage of macrophage differentiation, which was also shown in our NLRP3 inflammasome reconstituted HEK293T cells. There are several reasons accounting for the downregulation of PPARc protein by active caspase-1, such as decline of mRNA level, proteasome-mediated degradation, and/ or substrate cleavage, directly or indirectly controlled by caspase-1 activity. First, several lines of evidence have demonstrated that caspase-1-mediated production of IL-1b was implicated in the control of PPARc mRNA [40, 41] . Nevertheless, the gene expression of PPARc was not affected by WEHD treatment or caspase-1 knockdown (Fig. 6B,D) , thus excluding this possibility. Second, it is unlikely that proteasomes were involved in caspase-1-induced PPARc downregulation, since the proteasome inhibitor MG-132 could not block the decline of PPARc protein in inflammasomereconstituted 293T cells (Fig. 7D) . Although a recent study has suggested that PPARc might be cleaved by caspase-1 in adipocytes, these results failed to receive further support [22, 42] . Aside from these mechanisms, PPARc expression was likely to be controlled at the translational level [43] . The detailed mechanisms by which caspase-1 downregulates the expression of PPARc protein seem to be complicated and still need to be unveiled.
The role of PPARc in macrophage differentiation remains largely controversial. While in vitro experiments have suggested that PPARc promoted monocyte-to-macrophage differentiation in human leukemia cells, macrophage development in PPARc-deficient mice revealed no significant changes compared with WT [44, 45] . Interestingly, we found that PPARc exhibited a specific pattern of expression (Fig. 6A) , suggesting distinct roles for PPARc in the late stages of macrophage differentiation. Nevertheless, sustained activation of PPARc might result in apoptosis in unactivated differentiated macrophages [46] . Therefore, we speculated that caspase-1 activation was engaged to downregulate PPARc expression and activity during the late stage of macrophage differentiation. Prevention of PPARc downregulation of by WEHD or caspase-1 knockdown or knockout would considerably hinder the late stage of macrophage differentiation. Based on the experimental data discussed above, we propose a model in which PPARc is unnecessary for macrophage early stage differentiation. By contrast, PPARc acts as a negative modulator of the late stage of macrophage differentiation, which is regulated by active caspase-1. We speculate that the activation of NF-jB is important for macrophage late stage differentiation, and the presence of PPARc hindered the activity of NF-jB (Fig. 8K-M) .
A previous study has demonstrated a lower expression of caspases-1 in myelodysplastic syndromes, which could transform into AML [47] . Consistent with this, we got a striking result that caspase-1 was significantly downregulated in AML-M5b. Low expression of caspase-1 resulted in the decline of caspase-1 activity and inhibition of monocyte-to-macrophage differentiation, which might account for, at least in part, the accumulation of monocytic cells observed in leukemias. Notably, the human CASPASE-1 gene is mapped to 11q23, a site frequently involved in rearrangement in various cancers, including AML [48] . Hence, it is tempting to speculate that some mutations may occur in the CASPASE-1 gene, causing blunted activity of caspase-1. Future studies are needed to resolve these issue and will shed more light on the role for caspase-1 in differentiation therapy of AML.
Recent reports have begun to identify new caspase-1 functions beyond the confines of inflammation. Caspase-1 is able to mediate unconventional protein secretion, pyroptosis and inhibition of glycolysis in macrophages [49] . Our results, combined with these findings, suggest that caspase-1 may have a far broader role in controlling the monocyte-macrophage life cycle ranging from differentiation to activation and death. Consequently, dysregulation of caspase-1 activity may lead to aberrant control of monocyte-macrophage homeostasis in vivo and the induction of various diseases. Furthermore, we have put PPARc as the downstream target of caspase-1, and it might have different functions during the early and the late stages of macrophage differentiation. Therefore, in this study we have provided novel mechanistic insights and therapeutic prospects for several macrophage differentiation-associated diseases including leukemias. 
Materials and methods
Phagocytosis
Phagocytosis assays were conducted using fluorescent red latex beads (1 lm diameter, L-2778; Sigma-Aldrich). Latex beads were opsonized with complete medium (10% FBS in PRMI 1640) for 1 h at 37°C before the experiments. Opsonized beads were added to PMA-differentiated cells at a ratio of 10 : 1 and incubated at 37°C for 4 h. Phagocytosis was stopped with the addition of 1 mL ice-cold sterile phosphate-buffered saline (PBS). Cells were harvested and washed in ice-cold PBS three times and then analyzed by flow cytometry.
Flow cytometry
For analysis of surface antigen expression, cells were harvested at the indicated times and washed with ice-cold PBS and suspended at a concentration of 10 6 mL À1 in 100 lL buffer (0.1% BSA in PBS), and then were stained with PEanti-CD11b (eBioscience, San Diego, CA, USA) or PerCPCy5.5-anti-CD14 (BD Pharmingen, San Diego, CA, USA) for 30 min on ice. Appropriate isotype controls were also included. The cells were washed with ice-cold PBS and then analyzed. For apoptosis analysis, cells were stained with annexin V-FITC in the presence of propidium iodide using annexin V-FITC apoptosis detection kit according to the manufacturer's instruction (Beyotime, Shanghai, China).
For all experiments, cells were analyzed using a FACScalibur instrument (Becton Dickinson, Franklin Lakes, NJ, USA) and FLOWJO software (V. 7.6.4, TreeStar; FlowJo, Ashland, OR, USA).
Caspase-1 activity assay
Caspase-1 activity was assessed using a colorimetric caspase-1 assay kit (R&D Systems) according to the manufacturer's instructions. Briefly, THP-1 cells were harvested and lysed in ice-cold lysis buffer. Then the cell lysates (100-200 lg) were added to the final volume of 100 lL reaction buffer in the presence of DTT and caspase-1 specific substrate (WEHD-pNA). Samples were incubated at 37°C for 2 h and analyzed using a microplate reader at a wavelength of 405 nm. For assessment of active caspase-1 in cells, a Caspase-1 FLICA kit (FAM-YVAD-FMK, ImmunoChemistry Technologies, Bloomington, MN, USA) was used according to the manufacturer's manual.
Generation of cell lines stably expressing shRNA shRNA plasmid. Second generation packaging plasmids VSVG and M8.9 were used for lentivirus production and infection as described [50] . Briefly, HEK293T cells were cotransfected with the shRNA plasmid and plasmids expressing VSVG and M8.9 using Lipofectamine 2000 (Invitrogen/Thermo Fisher Scientific, Waltham, MA, USA). Virus supernatants were collected at 48 h post-transfection and filtered through a 0.45 lm filter (Invitrogen/ Thermo Fisher Scientific). For lentivirus infection of THP-1 and U937 cells, a total of 1 9 10 6 cells were plated in a six-well plate in 1 mL medium. Then 1 mL virus solution containing 8 lgÁmL
À1
polybrene (Sigma-Aldrich) was added to a total volume of 2 mL per well. The cells were centrifuged for 90 min at 800 g and 32°C; 24 h later, the transduction was repeated to enhance infection. The transduced cells were sorted for green fluorescent protein expression by flow cytometry.
CRISPR-CAS9 knockout
gRNA designed to target the common exons for all human caspase-1 isoforms was synthesized as follows: oligo no. 1, 5 0 -CACCGAAGCTGTTTATCCGTTCCAT-3 0 , and oligo no. 2, 5 0 -AAACATGGAACGGATAAACAGCTTC-3 0 ; it was cloned to lentiCRISPRv2 (one vector system) plasmids. gRNA designed to target the common exons for all human PPARc isforms was synthesized as follows: oligo no. 1, 5 0 -CACCGCTCCGTGGATCTCTCCGTAA-3 0 , and oligo no.
2, 5
0 -AAACTTACGGAGA GATCCACGGAGC-3 0 .
NLRP3 inflammasome reconstitution assays
Reconstitution of NLRP3 inflammasome was performed as previously described with minor modification [32] . In brief, 
Cytokine release assays
Cell culture supernatants were analyzed with ELISA kits (R&D Systems) for the detection of IL-1b, IL-6, IL-10 and TNFa according to the manufacturer's protocols.
Electrophoretic mobility shift assay 
Monocyte isolation
Fresh white cell buffy coats were provided by the JiangSu Province Blood Center (Nanjing, China) with Human Ethics Committee approval and informed consent. Bone marrow samples were obtained from AML-M5b patients at primary diagnosis and healthy donors with informed consent. Both human PBMCs and bone marrow monocytes from AML-M5b patients were isolated by Lymphoprep gradient centrifugation according to the manufacturer's instructions (Axis-Shield, Dundee, Scotland). Briefly, whole blood was diluted 1 ∶ 3 with PBS (containing 2 mM EDTA, pH 7.2); 30 mL of diluted blood was carefully overlain on 15 mL Lymphoprep in a 50 mL tube; it was immediately centrifuged at 800 g for 30 min (room temperature). The tube was carefully removed from the centrifuge; there were three layers, with clear supernatant at the top and opaque fluid containing the PBMCs in the middle; the opaque layer of PBMCs was transferred to a new 50 mL tube. It was washed twice with PBS and spun at 250 g for 10 min in a cooling centrifuge (4°C); then cells were cocultured in PRMI 1640 + 10% FBS for 2 h, floating cells were discarded, and attaching cells were washed five times with prewarmed PBS and collected.
The mononuclear cells were plated in 10 cm tissue-culture dishes, and permitted to adhere for 1 h at 37°C. Nonadherent cells were removed by washing the plates vigorously three times with prewarmed PBS. The adherent monocytes were suspended (2.5 9 10 5 mL À1 ) and incubated with M-CSF (100 ngÁmL À1 ) or GM-CSF (100 ngÁmL À1 ) for up to 7 days. Bone marrow monocytes were used immediately for RNA extraction. The AML cases were classified according to the French-American-British criteria.
Construction of expression vectors
cDNAs for human PPARc and IL-1b were amplified from total RNA from human PBMCs using specific primers listed below. Then the cDNAs were cloned into pCDNA3.1(-) vectors between the polyclonal sites XbaI and KpnI. All truncations were generated by standard molecular biology procedures. The PPARc mutants (D-A) and caspase-1 mutant (C285G) were generated using the Muta-direct sitedirected mutagenesis kit (SBS Genetech Co, Ltd, Beijing, China). All plasmids were verified by DNA sequencing. Primers used for amplifying relative cDNA: PPARc sense, 
Protein precipitation of cell culture supernatants
Cell culture supernatants were precipitated by methanol/ chloroform as described [51] . Briefly, cell culture supernatants were harvested and precipitated with an equal volume of methanol and 0.25 volumes of chloroform, then vortexed and centrifuged at 20 000 g for 10 min. The upper phase was discarded and the precipitate was washed in 1 volume of methanol followed by centrifuging for 10 min at 20 000 g. The protein pellet was dried at 55°C for about 30 min, resuspended in Laemmli buffer and boiled for 5 min at 99°C. The presence of caspase-1 and IL-1b was then analyzed by immunoblot.
Immunoblot analysis
Blots were blocked and probed with primary antibodies as follows: polyclonal rabbit anti-human pro-caspase-1 (sc-622, lot no. K2111; Santa Cruz Biotechnology, Dallas, TX, USA), polyclonal rabbit anti-human cleaved caspase-1 (D7F10; Cell Signaling Technology, Danvers, MA, USA), monoclonal mouse anti-human PPARc (sc-7273, Santa Cruz, lot no. C2914), biotinylated conjugated polyclonal goat anti-human ILÀ1b (R&D Systems), monoclonal mouse anti-FLAG (OctA-Probe, Santa Cruz) and monoclonal mouse anti-HA (26D11; Abmart, Berkeley Heights, NJ, USA). Appropriate horseradish peroxidase-conjugated secondary antibodies were used and proteins detected using lumiGLO reagents (Cell Signaling).
Quantitative and semiquantitative RT-PCR analysis
Total RNA extraction was performed using Trizol (Invitrogen/Thermo Fisher Scientific) according to the manufacturer's manual. RNA (3 lg) was reverse-transcribed with the PrimeScript 1st strand cDNA Synthesis Kit (TaKaRa, Dalian, China). Quantitative real-time PCR was performed in triplicate with SsoFast EvaGreen Supermix and C1000 Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA). Normalized expression was calculated using BIO-RAD CFX MANAGER software based on the threshold cycle (C T ) value using the 2 ÀDDCT method [52] . Semiquantitative
RT-PCR was performed using Premix Ex Taq (TaKaRa).
The primers used for RT-qPCR were as follows: CD11b: forward, 
Statistics
Data are expressed as the mean AE SEM of three independent experiments performed in triplicate. Student's unpaired t test and two-way analysis of variance (ANOVA)
were used for comparison of experimental groups. *P < 0.05, **P < 0.01, ***P < 0.001; and ns, not significant. Data for all experiments were analyzed with PRISM software (GraphPad Software, La Jolla, CA, USA).
